Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Antimicrobial Agents and Chemotherapy
|
February 1, 1995
Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones
R A Zabinski, K J Walker, A J Larsson, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1982
Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations
D E Zaske, R J Cipolle, J C Rotschafer, et al.
The Journal of Burn Care & Rehabilitation
|
September 1, 1989
The influence of serum albumin and alpha 1-acid glycoprotein on vancomycin protein binding in patients with burn injuries
H Z Zokufa, L D Solem, K A Rodvold, et al.
The Journal of Antimicrobial Chemotherapy
|
April 1, 1994
A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient
K Vance-Bryan, J C Rotschafer, S S Gilliland, et al.
Antimicrobial Agents and Chemotherapy
|
December 26, 2001
Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model
M L Peterson, L B Hovde, D H Wright, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 1993
Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system
R A Zabinski, K Vance-Bryan, A J Krinke, et al.
Pharmaceutical Research
|
July 1, 1992
An in vitro pharmacodynamic model to simulate antibiotic behavior of acute otitis media with effusion
K Vance-Bryan, T A Larson, M W Garrison, et al.
Pharmacotherapy
|
January 1, 1989
Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patients
H Z Zokufa, K A Rodvold, R A Blum, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1988
Vancomycin pharmacokinetics in patients with various degrees of renal function
K A Rodvold, R A Blum, J H Fischer, et al.
Therapeutic Drug Monitoring
|
January 1, 1983
Clinical use of a one-compartment model for determining netilmicin pharmacokinetic parameters and dosage recommendations
J C Rotschafer, K B Crossley, D E Zaske, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Antimicrobial Agents and Chemotherapy
|
February 1, 1995
Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones
R A Zabinski, K J Walker, A J Larsson, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1982
Gentamicin pharmacokinetics in 1,640 patients: method for control of serum concentrations
D E Zaske, R J Cipolle, J C Rotschafer, et al.
The Journal of Burn Care & Rehabilitation
|
September 1, 1989
The influence of serum albumin and alpha 1-acid glycoprotein on vancomycin protein binding in patients with burn injuries
H Z Zokufa, L D Solem, K A Rodvold, et al.
The Journal of Antimicrobial Chemotherapy
|
April 1, 1994
A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient
K Vance-Bryan, J C Rotschafer, S S Gilliland, et al.
Antimicrobial Agents and Chemotherapy
|
December 26, 2001
Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model
M L Peterson, L B Hovde, D H Wright, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 1993
Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system
R A Zabinski, K Vance-Bryan, A J Krinke, et al.
Pharmaceutical Research
|
July 1, 1992
An in vitro pharmacodynamic model to simulate antibiotic behavior of acute otitis media with effusion
K Vance-Bryan, T A Larson, M W Garrison, et al.
Pharmacotherapy
|
January 1, 1989
Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patients
H Z Zokufa, K A Rodvold, R A Blum, et al.
Antimicrobial Agents and Chemotherapy
|
June 1, 1988
Vancomycin pharmacokinetics in patients with various degrees of renal function
K A Rodvold, R A Blum, J H Fischer, et al.
Therapeutic Drug Monitoring
|
January 1, 1983
Clinical use of a one-compartment model for determining netilmicin pharmacokinetic parameters and dosage recommendations
J C Rotschafer, K B Crossley, D E Zaske, et al.
Page
of 9